Dr. Peter Attia Leaves CBS News After Epstein Emails

Attia Steps Aside from CBS News Contributor Role

Longevity expert Dr. Peter Attia has stepped aside from his newly established role as a contributor to CBS News. The decision follows the public release of his emails with the late convicted sex offender Jeffrey Epstein, which appeared in documents released by the U.S. Department of Justice on January 30.

Situational Overview

Dr. Attia's name was found more than 1,700 times in the trove of released Epstein files. A spokesperson stated that Attia stepped back to prevent his involvement from becoming a distraction for the network. In a public statement, Attia apologized for the emails, describing them as containing 'crude, tasteless banter' and expressing shame, while denying any involvement in criminal activity.

Business and Reputational Impact

The repercussions extend beyond his media role. On February 2, Dr. Attia also resigned from his position as chief science officer at David Protein, a company in which he was an investor. This indicates a significant professional fallout stemming from the Epstein disclosures, impacting his business and media affiliations.

Summary

The release of the Epstein documents has prompted swift professional consequences for Dr. Peter Attia, leading to his departure from both CBS News and David Protein. The events highlight the continued reputational risk for individuals associated with Jeffrey Epstein, impacting their roles in public and corporate spheres.

FAQ

Q: Why did Dr. Peter Attia leave CBS News?
A: He stepped aside after his email correspondence with convicted sex offender Jeffrey Epstein was made public as part of the Epstein files.

Q: What was Dr. Attia's role at CBS News?
A: He was appointed as a contributor, a role that was newly established and had not yet significantly commenced.

Q: Were there other professional consequences for Dr. Attia?
A: Yes, he also stepped down from his position as chief science officer of the protein-bar company David Protein.

Source: Reuters via Investing.com